StreetAlpha.app
Home › Stocks › DRTS

Alpha Tau Medical Ltd. (DRTS)

Healthcare
$11.76
▲ +3.93%
LAST CLOSE · NOV 20

Alpha Tau Medical develops Alpha DaRT, a localized radiation therapy technology for solid tumors. It last closed at $11.76 on Nov 20, up 3.93% on the day. Over the last 12 months DRTS insiders bought $0 of stock on the open market and sold $1.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is DRTS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold DRTS.

Key Stats

Last 12 months
Results
Net income
−$42.6M
Free cash flow
−$32.8M
Balance sheet
Cash & equivalents
$12.2M
At Dec 31
Shareholder equity
$77.1M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$27.3M−$27.3MFY2021FY2022: −$33.8M−$33.8MFY2022FY2023: −$29.2M−$29.2MFY2023FY2024: −$31.8M−$31.8MFY2024FY2025: −$42.6M−$42.6MFY2025

From DRTS's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 9). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on DRTS: 0 upgrades, 0 downgrades, 0 initiations
HC WainwrightReiterated
Nov 20Buy 
HC WainwrightReiterated
Nov 17Buy 

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on DRTS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on DRTS

Technical Analysis

DRTS · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 11% below its 20 day and 17% below its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 38). The nearest support is the Pivot at $11.75, and the nearest resistance the Pivot R1 at $12.19.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 7.0%/day
Key levels
$15.7952 week high+34.3%
$13.7950 day average+17.3%
$13.66Swing high (Oct 27)+16.2%
$13.65100 day average+16.1%
$13.0620 day average+11.1%
$12.19Pivot R1+3.7%
$11.76Last close
$11.75Pivot−0.1%
$11.51Swing low (Jul 17)−2.1%
$11.31Pivot S1−3.8%
$11.04200 day average−6.1%
$3.4352 week low−70.8%
Indicators
RSI (14)38.19Weak, oversold below 30Neutral
MACD-0.49Below its signal lineBearish
Stochastic15.4Near the bottom of its rangeOversold
ADX (14)25.2Trending down
Williams %R-76.6Oversold below −80, overbought above −20Neutral
CCI (20)-152.2Oversold below −100, overbought above 100Oversold
Rate of change−14.3%Change over 10 sessionsBearish
ATR (14)$0.82Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for DRTS

What happened before

See how DRTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow DRTS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How DRTS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for DRTSHow many large options trades hit DRTS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

DRTS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲58 buying vs 30 selling
  • ▲Shares held by funds +42.2%
  • ▲Funds holding +21
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding9574+28.4%
In funds' top 10110.0%
Held by funds–––
New / increased34 / 2426 / 17+34.9%
Reduced / sold out16 / 1411 / 6+76.5%
Put/call ratio0.03––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DRTS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

DRTS Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$1.6M9 sales · 1 insider
77% of the selling was under pre-arranged trading plans.
2026-06 sold $979K2026-07 sold $292K2026-08 sold $291KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 21Raphi LevyCFOSale plan2,871$15.00$43K
Aug 11Raphi LevyCFOSale plan17,730$14.00$248K
Jul 6Raphi LevyCFOSale plan2,270$14.00$32K
Jul 2Raphi LevyCFOSale plan17,873$13.00$232K
Jul 1Raphi LevyCFOSale plan2,127$13.02$28K
Jun 30Raphi LevyCFOSale plan20,000$12.00$240K
Every insider buy and sale for DRTS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See DRTS insider trades →

From SEC Form 4 filings by DRTS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DRTS is in one of them and how their past DRTS trades turned out.

DRTS in the AI portfolios
Loading…

DRTS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DRTS in an article yet. Here's the latest on the wider market.

DRTS in the news

About Alpha Tau Medical

Alpha Tau Medical is based in Jerusalem, Israel, and develops Alpha DaRT, a localized radiation therapy technology for solid tumors. It uses alpha particles, which travel only short distances, to treat tumors in place. The company is running clinical trials for skin, head and neck, pancreatic and brain tumors, including cancers that are hard to remove surgically or not well served by standard care. Its intended customers are cancer patients and the hospitals and medical centers that treat them.

Headquarters
Jerusalem, Israel